Grifols (GIKLY) Net Cash Flow (QoQ) (2010 - 2020)

Grifols (GIKLY) Net Cash Flow (QoQ) (2010 - 2020) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 59.92%
Mar 31, 2019 -141.23%
Jun 30, 2018 -312.72%
Mar 31, 2018 -94.87%
Jun 30, 2017 -93.50%
Mar 31, 2017 5,379.98%
Dec 31, 2016 88.08%
Dec 31, 2015 -577.30%
Sep 30, 2015 -81.08%
Jun 30, 2015 410.58%
Mar 31, 2013 107.76%
Dec 31, 2012 -395.97%
Sep 30, 2012 -63.10%
Jun 30, 2012 137,778.57%
Mar 31, 2012 -99.64%
Dec 31, 2011 -97.03%
Sep 30, 2011 589.54%
Jun 30, 2011 1,035.35%
Mar 31, 2011 -125.97%
Dec 31, 2010 67.74%